Good morning, all. Damian Garde here filling in for Ed Silverman on this, the start of another week replete with meetings, deadlines, and all the other trappings of working life. Here are some headlines from around the pharma world to get your morning started. May you conquer all that you must this week, and do keep in touch.
After months of rumor and negotiation, German drug maker Stada is finally getting sold, Bloomberg tells us. Private equity magnates Bain Capital and Cinven have teamed up to pay $5.6 billion for Stada, a figure that is nearly 50 percent above its value before takeout talks began. Bain and Cinven have agreed to honor the company’s union contracts and refrain from layoffs for four years.